Profile | GDS5420 / 235650_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 120.33 | 44 |
GSM1296119 | B_lesional_pre-dose | 82.82 | 37 |
GSM1296076 | C_lesional_pre-dose | 128.68 | 47 |
GSM1296092 | D_lesional_pre-dose | 64.07 | 37 |
GSM1296103 | E_lesional_pre-dose | 43.08 | 29 |
GSM1296078 | F_lesional_pre-dose | 127.89 | 47 |
GSM1296107 | G_lesional_pre-dose | 125.71 | 44 |
GSM1296109 | H_lesional_pre-dose | 105.96 | 41 |
GSM1296080 | I_lesional_pre-dose | 49.99 | 32 |
GSM1296090 | J_lesional_pre-dose | 73.08 | 38 |
GSM1296074 | K_lesional_pre-dose | 74.61 | 39 |
GSM1296111 | L_lesional_pre-dose | 168.06 | 48 |
GSM1296099 | M_lesional_pre-dose | 105.03 | 42 |
GSM1296086 | O_lesional_pre-dose | 73.82 | 38 |
GSM1296117 | P_lesional_pre-dose | 131.86 | 44 |
GSM1296113 | Q_lesional_pre-dose | 118.35 | 41 |
GSM1296096 | R_lesional_pre-dose | 123.02 | 45 |
GSM1296105 | S_lesional_pre-dose | 152.17 | 47 |
GSM1296098 | T_lesional_pre-dose | 119.87 | 43 |
GSM1296101 | U_lesional_pre-dose | 100.03 | 41 |
GSM1296121 | V_lesional_pre-dose | 128.73 | 45 |
GSM1296088 | W_lesional_pre-dose | 83.5 | 39 |
GSM1296082 | X_lesional_pre-dose | 71.36 | 38 |
GSM1296115 | Y_lesional_pre-dose | 92.34 | 39 |
GSM1296084 | Z_lesional_pre-dose | 121.33 | 44 |
GSM1296072 | B_lesional_day8 | 130.6 | 44 |
GSM1296069 | L_lesional_day8 | 145.64 | 45 |
GSM1296071 | P_lesional_day8 | 143.2 | 44 |
GSM1296070 | Y_lesional_day8 | 126.73 | 42 |
GSM1296073 | V_lesional_day8 | 112.04 | 43 |
GSM1296034 | A_lesional_day15 | 139.4 | 45 |
GSM1296041 | G_lesional_day15 | 113.4 | 42 |
GSM1296035 | R_lesional_day15 | 107.33 | 43 |
GSM1296038 | U_lesional_day15 | 99.36 | 41 |
GSM1296047 | B_lesional_day15 | 95.05 | 38 |
GSM1296039 | E_lesional_day15 | 54.81 | 32 |
GSM1296042 | H_lesional_day15 | 173.06 | 49 |
GSM1296043 | L_lesional_day15 | 159.78 | 47 |
GSM1296037 | M_lesional_day15 | 104.53 | 41 |
GSM1296046 | P_lesional_day15 | 80.81 | 35 |
GSM1296044 | Q_lesional_day15 | 124.09 | 42 |
GSM1296045 | Y_lesional_day15 | 137.67 | 44 |
GSM1296025 | C_lesional_day15 | 87.77 | 40 |
GSM1296033 | D_lesional_day15 | 49.85 | 31 |
GSM1296027 | I_lesional_day15 | 147.85 | 49 |
GSM1296032 | J_lesional_day15 | 76.19 | 37 |
GSM1296024 | K_lesional_day15 | 104.94 | 43 |
GSM1296031 | W_lesional_day15 | 151.47 | 47 |
GSM1296028 | X_lesional_day15 | 48.73 | 31 |
GSM1296029 | Z_lesional_day15 | 154.66 | 48 |
GSM1296026 | F_lesional_day15 | 99.9 | 42 |
GSM1296030 | O_lesional_day15 | 105.96 | 45 |
GSM1296040 | S_lesional_day15 | 28.56 | 22 |
GSM1296036 | T_lesional_day15 | 72.38 | 35 |
GSM1296048 | V_lesional_day15 | 128.87 | 44 |
GSM1296059 | A_lesional_day43 | 92.3 | 41 |
GSM1296066 | G_lesional_day43 | 116.69 | 42 |
GSM1296060 | R_lesional_day43 | 125.5 | 45 |
GSM1296063 | U_lesional_day43 | 129.97 | 45 |
GSM1296064 | E_lesional_day43 | 60.46 | 34 |
GSM1296067 | H_lesional_day43 | 169.26 | 48 |
GSM1296062 | M_lesional_day43 | 57.16 | 33 |
GSM1296068 | Q_lesional_day43 | 171.84 | 47 |
GSM1296050 | C_lesional_day43 | 100.39 | 41 |
GSM1296057 | D_lesional_day43 | 138.14 | 46 |
GSM1296052 | I_lesional_day43 | 185.11 | 52 |
GSM1296054 | J_lesional_day43 | 70.11 | 35 |
GSM1296049 | K_lesional_day43 | 213.65 | 54 |
GSM1296055 | W_lesional_day43 | 179.05 | 50 |
GSM1296053 | X_lesional_day43 | 169.17 | 50 |
GSM1296058 | Z_lesional_day43 | 221.38 | 54 |
GSM1296051 | F_lesional_day43 | 86.48 | 40 |
GSM1296056 | O_lesional_day43 | 109.94 | 44 |
GSM1296065 | S_lesional_day43 | 151.16 | 47 |
GSM1296061 | T_lesional_day43 | 140.67 | 46 |
GSM1296095 | A_non-lesional_pre-dose | 58.54 | 34 |
GSM1296120 | B_non-lesional_pre-dose | 134.18 | 44 |
GSM1296077 | C_non-lesional_pre-dose | 114.08 | 44 |
GSM1296093 | D_non-lesional_pre-dose | 159.56 | 48 |
GSM1296104 | E_non-lesional_pre-dose | 38.9 | 27 |
GSM1296079 | F_non-lesional_pre-dose | 118.06 | 45 |
GSM1296108 | G_non-lesional_pre-dose | 130.61 | 44 |
GSM1296110 | H_non-lesional_pre-dose | 260.23 | 55 |
GSM1296081 | I_non-lesional_pre-dose | 110.85 | 44 |
GSM1296091 | J_non-lesional_pre-dose | 27.09 | 23 |
GSM1296075 | K_non-lesional_pre-dose | 125.58 | 46 |
GSM1296112 | L_non-lesional_pre-dose | 226.26 | 52 |
GSM1296100 | M_non-lesional_pre-dose | 82.22 | 38 |
GSM1296087 | O_non-lesional_pre-dose | 112.66 | 46 |
GSM1296118 | P_non-lesional_pre-dose | 153.86 | 46 |
GSM1296114 | Q_non-lesional_pre-dose | 94.04 | 37 |
GSM1296097 | R_non-lesional_pre-dose | 153.1 | 48 |
GSM1296106 | S_non-lesional_pre-dose | 92.35 | 39 |
GSM1296102 | U_non-lesional_pre-dose | 69.63 | 35 |
GSM1296122 | V_non-lesional_pre-dose | 140.82 | 45 |
GSM1296089 | W_non-lesional_pre-dose | 148.68 | 47 |
GSM1296083 | X_non-lesional_pre-dose | 155.16 | 48 |
GSM1296116 | Y_non-lesional_pre-dose | 190.7 | 49 |
GSM1296085 | Z_non-lesional_pre-dose | 161.64 | 49 |